Medical marijuana for multiple sclerosis in Arizona (2026).

Multiple sclerosis is in Arizona’s medical marijuana law, but not where most people look for it. It is not on the short list of diseases that qualify by name, next to cancer and glaucoma. It appears as an example inside a symptom. That detail takes two minutes to understand, and it changes what you should say when you sit down with the certifying physician.

Where MS sits in the statute

ARS §36-2801(3) defines a “debilitating medical condition” in three parts. Part (a) lists diagnoses that qualify on their own: cancer, glaucoma, HIV, AIDS, hepatitis C, ALS, Crohn’s disease and agitation of Alzheimer’s disease. Part (b) covers any chronic or debilitating disease, or its treatment, that produces one of five symptoms. The fifth reads: “severe and persistent muscle spasms, including those characteristic of multiple sclerosis.”

So, strictly, the qualifying condition is the spasticity, not the diagnosis code. For someone whose MS causes stiffness or spasms this is rarely a hurdle, but it means the conversation should be about what your body is doing, not only about the letters on your chart.

MS can also qualify through the other doors in part (b). Severe and chronic pain is a separate symptom on the same list, and so is severe nausea. The full list of Arizona qualifying conditions sets out every route.

What the evidence actually supports

The most thorough review is the National Academies of Sciences report from 2017, which graded the published trials for each common medical claim. For MS it found substantial evidence that oral cannabinoids improve patient-reported spasticity, and only limited evidence when spasticity was measured by a clinician.

That gap matters. People in the trials said they felt less stiff, and that is a real outcome. The objective scales moved less. The American Academy of Neurology came to a similar view in its 2014 systematic review: oral cannabis extract was rated effective for patient-reported spasticity and for central pain, while the evidence for smoked cannabis was insufficient to judge.

Notice what was tested. Most trials used standardized products: nabiximols (a THC and CBD mouth spray sold in other countries but not approved in the US), oral cannabis extract and nabilone. A dispensary gummy is not the same thing, and a result from a pharmaceutical trial does not transfer to it automatically.

Pain and sleep

Neuropathic pain is common in MS, and pain qualifies in Arizona in its own right. The same National Academies report found substantial evidence that cannabis is effective for chronic pain in adults generally; our guide to medical marijuana for chronic pain goes through that evidence and the dosing questions.

On sleep, the report found moderate evidence that cannabinoids, mainly nabiximols, improve short-term sleep in people whose sleep is disturbed by conditions that include MS. Short-term is the important word: there is little data on what happens over years.

Cautions that are specific to MS

• Thinking and memory. MS can slow processing speed and affect memory, and THC can do the same in anyone. If you notice cognitive changes, they are worth mentioning to your neurologist rather than putting down to the disease.
• Balance. Dizziness is a common THC side effect. With gait or balance problems already in the picture, that is a fall risk. Start low, and not on the stairs.
• Stacked sedation. Baclofen, tizanidine and gabapentin all cause drowsiness, and THC adds to it. Read how cannabis interacts with common medications before you combine them, and tell the prescriber.
• Driving. A card is not a defense to impaired driving. See what a card means for driving, jobs and firearms.

None of this replaces disease-modifying therapy. Cannabis is studied for symptoms, not for the course of MS itself.

Getting certified with MS

1. Gather what you have. Neurologist notes that mention spasticity, an MRI report, a list of the medications you have tried. Not legally required, but it shortens the visit.
2. Describe the spasms concretely. How often, at what time of day, what they stop you doing, and what has or has not helped. That is the statutory question.
3. File the state application yourself in the AZDHS portal and pay $150, or $75 with SNAP proof. There is no veteran rate.
4. Wait up to 10 business days, then download the card from the portal. It is valid for two years.

The whole sequence is set out in how to get an Arizona medical card in 2026.

If mobility makes dispensary trips hard, a registered caregiver can buy on your behalf. The caregiver card has its own $200 state fee and its own rules; see the Arizona caregiver card.

Does the card say I have MS?

No. The card AZDHS issues shows your name, photo, address, date of birth, issue and expiry dates and a card number. Your condition is not printed on it.

Should I tell my neurologist?

Yes. Cannabis can change how you describe fatigue, cognition and balance at a check-up, and your neurologist is reading those reports to judge how the disease is behaving.

This article is informational and does not constitute medical advice. Talk to your neurologist before adding cannabis to an MS treatment plan, and confirm fees and rules at medicalmarijuana.azdhs.gov.